Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
17.04
0.00 (0.00%)
At close: Sep 16, 2026, 4:00 PM EDT
17.03
-0.01 (-0.06%)
After-hours: Sep 16, 2026, 4:15 PM EDT
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $884.7 million as of September 16, 2026. Its market cap has increased by 21.99% in one year.
Market Cap
884.70M
Enterprise Value
535.61M
1-Year Change
21.99%
Ranking
Category
Stock Price
$17.04
ChartMarket Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $884.70M, an increase of 19.44%. That is a compound annual growth rate of 1.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 884.70M | -6.69% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 931.55M |
| Lexicon Pharmaceuticals | 903.26M |
| Solid Biosciences | 888.90M |
| Wave Life Sciences | 880.81M |
| Immix Biopharma | 876.36M |
| Avalo Therapeutics | 860.49M |
| Candel Therapeutics | 856.24M |
| Ardelyx | 844.75M |